Cargando…

A randomized, intraindividual, non‐inferiority, Phase III study comparing daylight photodynamic therapy with BF‐200 ALA gel and MAL cream for the treatment of actinic keratosis

BACKGROUND: The most effective treatment modality for actinic keratosis (AK) is photodynamic therapy (PDT). Major obstacles of PDT are the need of a special illumination device and pain accompanying the illumination. These issues may be overcome by replacing an artificial high‐power light source wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dirschka, T., Ekanayake‐Bohlig, S., Dominicus, R., Aschoff, R., Herrera‐Ceballos, E., Botella‐Estrada, R., Hunfeld, A., Kremser, M., Schmitz, B., Lübbert, H., Puig, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles and Short Reports Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585804/ https://www.ncbi.nlm.nih.gov/pubmed/30022544 http://dx.doi.org/10.1111/jdv.15185

Ejemplares similares

MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera
por: Cantisani, Carmen, et al.
Publicado: (2016)

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
por: Dirschka, T, et al.
Publicado: (2013)

A Review of MAL-PDT for the Treatment Strategy of Actinic Keratosis: Broader Clinical Perspectives Beyond the Data and Guideline Recommendations
por: Szeimies, Rolf-Markus, et al.
Publicado: (2023)

Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF‐200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials
por: Novak, Ben, et al.
Publicado: (2021)

Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis – a review of the literature
por: Nguyen, Mimi, et al.
Publicado: (2019)

EHMTI-0093. Investigation of 5-HT2B receptor pathways with relevance to a mouse migraine model
por: Kremser, M, et al.
Publicado: (2014)

Daylight Photodynamic Therapy Versus 5-Fluorouracil for the Treatment of Actinic Keratosis: A Case Series
por: Galimberti, Gaston Nestor
Publicado: (2018)

EHMTI-0092. Activation of the 5-HT2B receptor induces dural plasma protein extravasation in a mouse migraine model
por: Hunfeld, A, et al.
Publicado: (2014)

Equivalent efficacy of indoor daylight and lamp‐based 5‐aminolevulinic acid photodynamic therapy for treatment of actinic keratosis
por: Ruiz, Alberto J., et al.
Publicado: (2023)

Daylight Science and Daylighting Technology
por: Kittler, Richard, et al.
Publicado: (2012)

Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia
por: See, Jo‐Ann, et al.
Publicado: (2015)

The impact of occlusive vs non‐occlusive application of 5‐aminolevulinic acid (BF‐200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within‐patient comparison trial
por: Meierhofer, C., et al.
Publicado: (2020)

Activation of 5-HT2B-receptors leads to increased vasodilation in mouse dura mater blood vessels
por: Segelcke, D, et al.
Publicado: (2013)

Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin
por: de Bruijn, Henriëtte S., et al.
Publicado: (2016)

EHMTI-0219. Quantitative histological examinations of inter- and intraindividual differences in the dural vasculature of the mouse
por: Mecheri, B, et al.
Publicado: (2014)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
por: Torres, Abel, et al.
Publicado: (2007)

Is a 4 J/cm(2) PpIX-Weighted Simulated Daylight (SDL-PDT) Dose Still Efficient for Photodynamic Therapy of Actinic Keratosis?
por: Fronville, Mathilde, et al.
Publicado: (2023)

A novel hydrogel‐based moisturizing cream composed of hyaluronic acid for patients with xerosis: An intraindividual comparative analysis
por: Ha, Nam Gyoung, et al.
Publicado: (2023)

Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project
por: MORTON, Colin, et al.
Publicado: (2023)

Fully home‐based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study
por: García‐Gil, Miguel Fernando, et al.
Publicado: (2022)

Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
por: STOCKFLETH, Eggert, et al.
Publicado: (2023)

Measuring Daylight: A Review of Dosimetry in Daylight Photodynamic Therapy
por: O’Mahoney, Paul, et al.
Publicado: (2019)

Simple mathematical models to link climate-based daylight metrics with daylight factor metrics and daylighting design implications
por: Li, Shuyang, et al.
Publicado: (2023)

High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in Australia
por: See, Jo-Ann, et al.
Publicado: (2017)

Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study
por: Schaller, Martin, et al.
Publicado: (2016)

How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results
por: Steeb, Theresa, et al.
Publicado: (2021)

Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
por: Briatico, Giulia, et al.
Publicado: (2023)

THE CHEMISTRY OF DAYLIGHT VISION
por: Bliss, Alfred Frederick
Publicado: (1946)

Treatment of face and scalp solar (actinic) keratosis with daylight‐mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study
por: Spelman, Lynda, et al.
Publicado: (2015)

The best time for extubation—daylight at the end of the tunnel?
por: Swanson, Jonathan R., et al.
Publicado: (2021)

‘The Waste of Daylight’: Rhythmicity, Workers’ Health and Britain’s Edwardian Daylight Saving Time Bills
por: Hussey, Kristin D
Publicado: (2021)

When Seborrheic Keratosis Is Wearing a Mask
por: Sousa, Cristina, et al.
Publicado: (2020)

Daylight Photodynamic Therapy: An Update
por: Lee, Chaw-Ning, et al.
Publicado: (2020)

Impact of Daylight Saving Time on the Clinical Laboratory
por: Ehlers, Alexandra, et al.
Publicado: (2018)

On the Importance of Intraindividual Variability in Cognitive Development
por: de Ribaupierre, Anik, et al.
Publicado: (2018)

Daylight savings time and myocardial infarction
por: Sandhu, Amneet, et al.
Publicado: (2014)

Daylight photodynamic therapy for Bowen's disease()()
por: Martins, Carla Corrêa, et al.
Publicado: (2020)

Daylight space debris laser ranging
por: Steindorfer, Michael A., et al.
Publicado: (2020)

Daylight affects human thermal perception
por: Chinazzo, Giorgia, et al.
Publicado: (2019)

Daylight and School Performance in European Schoolchildren
por: Baloch, Ramen Munir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sli36lj2cisami664448qaqd1n